[1] |
HUO Yanfei, TIAN Yuejie, XU Lili, XIE Yanjun, CHANG Hong, SUN Chunxiao, LI Xia.
535 reports of new and serious adverse drug reactions caused by preparations of lappaconitine hydrobromide
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 921-926.
|
[2] |
DU Ying, XIE Yanming, WANG Lianxin, GENG Hongjiao, LI Xiangjie.
Clinical characteristics and drug combination analysis of Lianhua Qingwen capsules (granules) in the real world
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 296-300.
|
[3] |
ZHENG Jinfeng, WANG Jinghong.
Pharmaceutical care of one case of malignant arrhythmia induced by multidrug combination
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1279-1281.
|
[4] |
HUANG Yanli, XIE Yanming, WANG Lianxin, SUN Linxi, LIU Huan, ZHUANG Yunni.
Clinical applications of Ciwujia injection in elderly patients in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 935-939.
|
[5] |
DONG Hanshuo, SUN Li, ZHAO Xiaoxiao, WANG Lianxin, YU Xiaokang, XIE Yanming.
Clinical characteristics and drug combination analysis of elemene injectable emulsion in the elderly in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 845-850.
|
[6] |
ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei.
Analysis of neuropsychiatric adverse reactions caused by zolpidem
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
|
[7] |
XIANG Yufang, SUN Hui, CHEN Yue, WANG Ningsheng, LUO Shishu, ZHANG Zhi, FENG Bianling.
Medication safety and combined medication in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 313-316.
|
[8] |
CHENG Jinlian, OUYANG Huitian, JIN Hongtao, ZHU Xueqi, XIAO Shuang, LEI Xiang, GAO Chunsheng, LIU Qingquan.
Thoughts and Suggestions on Safety Evaluation of Combined use of Traditional Chinese Medicine in Clinical Research
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 4-10.
|
[9] |
YUAN Shoujun.
Mathematical Flaws of Commonly Used Calculating Methods of Multi-drug Combination and Solution Based on One Belt and One Line Model Method
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 11-17.
|
[10] |
ZENG Huansi, ZHONG Caini, ZHONG Yilin, PENG Chenchen, ZHANG Xuan.
Analysis of 129 Cases of Adverse Reactions and Clinical Application of Plasma Concentration Monitoring of Olanzapine
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 818-822.
|
[11] |
LYU Tianyi, KUANG Li, CHEN Mingying.
Analysis of 1073 Cases of Clinical Use of Reduning Injection by Pareto Chart and Fishbone Diagram
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 745-748.
|
[12] |
CHEN Chong, GE Ziruo, WANG Lin, CHEN Zhihai.
Analysis and Prospect of Domestic and Foreign Plague Antibacterial Treatment Plan
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(1): 1-5.
|
[13] |
XU Shungui.
105 Cases of Adverse Drug Reactions Indcued by Ibuprofen in Our Hosptial
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 164-167.
|
[14] |
LIU Chen, CHU Yanqi, YAN Suying, JIN Chao, LIU Tong, XING Liqiu, ZHANG Xiao.
Analysis of 93 Reports of Adverse Drug Reactions Induced by Edaravone Injection
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 174-178.
|
[15] |
LI Yiqun, SUN Zhenxiao.
Study Progress of Norcantharidin Based Structural Modification and Drug Combination for Cancer
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 179-184.
|